Special Instructions 016 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002

This Special Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response reopens Area of Interest #5 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Under Special Instructions 016, BARDA seeks proposals to repurpose existing therapeutics as medical countermeasures against chemical threats in "AOI #5: ReDirect (Repurposing Drugs in Response to Chemical Threats)."

The Special Notice seeks proposals by March 31, 2022 to identify drug candidates for repurposing that are FDA approved or have completed Phase 2 trials, with rationale for efficacy as chemical threat countermeasures against exposures to cyanide, opioids, nerve agents, chlorine, or sulfur mustard. Eligible candidates include those with drugs that could be repurposed. Interested parties should submit an abstract detailing their proposed candidate drug, development status, and rationale for effectiveness. Multiple awards are anticipated dependent upon scientific and technical merit, fit with goals, and available funding not to exceed $750,000 total per award.